Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Ropivacaine

    Client Email Product

    Ropivacaine

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    53
    US DMFs Filed

    US DMFs Filed

    16
    CEP/COS Certifications

    CEP/COS Certifications

    9
    JDMFs Filed

    JDMFs Filed

    1
    Other Certificates

    Other Certificates

    11
    Other Suppliers

    Other Suppliers

    38
    API REF. PRICE (USD / KG)
    1,356

    API Market Place

    15
    INTERMEDIATES
    10
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    63
    Europe

    Europe

    48
    Canada

    Canada

    6
    Australia

    Australia

    0

    South Africa

    South Africa

    11
    Uploaded Dossiers

    Uploaded Dossiers

    17
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    2
    EXCIPIENTS
    3
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    6

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    2

    News

    28
    REF STANDARD

    EDQM

    3

    USP

    3

    JP

    0

    Other Listed Suppliers

    15
    SERVICES

    0

    left grey arrow
    right gray arrow
    • SOLUTION;INJECTION - 100MG/10ML (10MG/ML)
    • SOLUTION;INJECTION - 100MG/20ML (5MG/ML)
    • SOLUTION;INJECTION - 150MG/30ML (5MG/ML)
    • SOLUTION;INJECTION - 150MG/20ML (7.5MG/ML)
    • SOLUTION;INJECTION - 1GM/200ML (5MG/ML)
    • SOLUTION;INJECTION - 200MG/20ML (10MG/ML)
    • SOLUTION;INJECTION - 200MG/100ML (2MG/ML)
    • SOLUTION;INJECTION - 20MG/10ML (2MG/ML)
    • SOLUTION;INJECTION - 400MG/200ML (2MG/ML)
    • SOLUTION;INJECTION - 40MG/20ML (2MG/ML)
    • SOLUTION;INJECTION - 500MG/100ML (5MG/ML)
    • SOLUTION;INJECTION - 50MG/10ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • SOLUTION;INJECTION - 75MG/10ML (7.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    Full View ScreenFull Screen View
    Lupin's Generic Ropivacaine Hydrochloride Receives Approval in the U.S.
    Lupin's Generic Ropivacaine Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208555

    FDA
    22 Jan 2024
    Share Share
    Enforcement Report - Week of December 13, 2023
    Enforcement Report - Week of December 13, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-13-2023-38736.pdf

    FDA
    13 Dec 2023
    Share Share
    Enforcement Report - Week of June 7, 2023
    Enforcement Report - Week of June 7, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf

    FDA
    07 Jun 2023
    Share Share
    Cali Biosciences Initiates Second Phase III Study of CPL-01
    Cali Biosciences Initiates Second Phase III Study of CPL-01

    https://www.prnewswire.com/news-releases/cali-biosciences-initiates-second-phase-iii-study-of-cpl-01-long-acting-ropivacaine-to-decrease-post-operative-pain-and-reduce-or-eliminate-opioid-use-and-presents-consistent-and-predictable-pk-results-across-multiple-surgeries-301841948.html

    PR NEWSWIRE
    05 Jun 2023
    Share Share
    Cali Biosciences Initiates Phase III Studies of CPL-01 (Long-Acting Ropivacaine)
    Cali Biosciences Initiates Phase III Studies of CPL-01 (Long-Acting Ropivacaine)

    https://www.prnewswire.com/news-releases/cali-biosciences-initiates-phase-iii-studies-of-cpl-01-long-acting-ropivacaine-to-decrease-post-operative-pain-and-reduce-or-eliminate-opioid-use-301801255.html

    PR NEWSWIRE
    18 Apr 2023
    Share Share
    Enforcement Report - Week of April 5, 2023
    Enforcement Report - Week of April 5, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-5-2023-55870.pdf

    FDA
    05 Apr 2023
    Share Share
    Gland's Generic Ropivacaine Hydrochloride Receives Approval in the U.S.
    Gland's Generic Ropivacaine Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210102

    FDA
    18 Aug 2022
    Share Share
    Cali Bio Announces Successful Results in Phase IIb Study of Long-Acting CPL-01
    Cali Bio Announces Successful Results in Phase IIb Study of Long-Acting CPL-01

    https://www.prnewswire.com/news-releases/cali-biosciences-announces-successful-results-in-phase-iib-study-of-long-acting-ropivacaine-cpl-01-for-non-opioid-treatment-of-post-operative-pain-301505715.html

    PRNEWSWIRE
    21 Mar 2022
    Share Share
    Cali Biosciences Presents Phase IIa Clinical Data on CPL-01, Ropivacaine
    Cali Biosciences Presents Phase IIa Clinical Data on CPL-01, Ropivacaine

    https://www.asiaone.com/business/asra-2021-cali-biosciences-presents-phase-iia-clinical-data-cpl-01-long-acting-ropivacaine

    ASIAONE
    18 Nov 2021
    Share Share
    Hikma`s Generic Ropivacaine Hydrochloride Receives Approval In US
    Hikma`s Generic Ropivacaine Hydrochloride Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214074

    FDA
    25 Jul 2020
    Share Share
    Enforcement Report - Week of July 1, 2020
    Enforcement Report - Week of July 1, 2020

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-1-2020-1593586904.pdf

    FDA
    01 Jul 2020
    Share Share
    Fresenius Kabi's Recall of Ketorolac Results In QuVa Pharma® Recall of Compounded Sterile Product (R.E.C.K.)
    Fresenius Kabi's Recall of Ketorolac Results In QuVa Pharma® Recall of Compounded Sterile Product (R.E.C.K.)

    https://www.pharmacompass.com/pdf/news/fresenius-kabis-recall-of-ketorolac-results-in-quva-pharma-recall-of-compounded-sterile-product-reck-1588048740.pdf

    FDA
    28 Apr 2020
    Share Share
    PharMEDium Services Issues Voluntary Nationwide Recall of Certain Lots of Compounded Sterile Products
    PharMEDium Services Issues Voluntary Nationwide Recall of Certain Lots of Compounded Sterile Products

    https://www.pharmacompass.com/pdf/news/pharmedium-services-issues-voluntary-nationwide-recall-of-certain-lots-of-compounded-sterile-products-1587014091.pdf

    FDA
    15 Apr 2020
    Share Share
    Caplin`s Generic Ropivacaine Hydrochloride Receives Approval in US
    Caplin`s Generic Ropivacaine Hydrochloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212808

    FDA
    14 Apr 2020
    Share Share
    TLC announces completion of $27 M financing
    TLC announces completion of $27 M financing

    https://www.biospectrumasia.com/news/25/14766/tlc-announces-completion-of-27-m-financing.html

    BIOSPECTRUMASIA
    28 Oct 2019
    Share Share
    Enforcement Report - Week of December 26, 2018
    Enforcement Report - Week of December 26, 2018

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-26-2018-1545811500.pdf

    FDA
    26 Dec 2018
    Share Share
    Gland Pharma's Generic Ropivacaine HCl Receives Tentative Approval in US
    Gland Pharma's Generic Ropivacaine HCl Receives Tentative Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210102

    FDA
    04 Oct 2018
    Share Share
    Enforcement Report - Week of August 15, 2018
    Enforcement Report - Week of August 15, 2018

    https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-August-15-2018-1534336681.pdf

    FDA
    15 Aug 2018
    Share Share
    Naropin (ropivacaine hydrochloride) : Fresenius Kabi USA v. Custopharm, Inc.
    Naropin (ropivacaine hydrochloride) : Fresenius Kabi USA v. Custopharm, Inc.

    https://www.pharmacompass.com/pdf/news/naropin-ropivacaine-hydrochloride-fresenius-kabi-usa-v-custopharm-inc-1533729310.pdf

    PATENT LITIGATION
    07 Aug 2018
    Share Share
    Enforcement Report - Week of July 25, 2018
    Enforcement Report - Week of July 25, 2018

    https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-July-25-2018-1532506531.pdf

    FDA
    25 Jul 2018
    Share Share
    InfoRLife Generic Ropivacaine Hcl Receives Approval In US
    InfoRLife Generic Ropivacaine Hcl Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206166

    FDA
    14 Jun 2018
    Share Share
    Akorn’s Generic Ropivacaine Hydrochloride Receives Approval In US
    Akorn’s Generic Ropivacaine Hydrochloride Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204636

    FDA
    19 Mar 2018
    Share Share
    Enforcement Report - Week of February 28, 2018
    Enforcement Report - Week of February 28, 2018

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2018-1519803579.pdf

    FDA
    28 Feb 2018
    Share Share
    Enforcement Report - Week of November 1, 2017
    Enforcement Report - Week of November 1, 2017

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-1-2017-1509512060.pdf

    FDA
    01 Nov 2017
    Share Share
    Enforcement Report - Week of July 12, 2017
    Enforcement Report - Week of July 12, 2017

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-12-2017-1499837241.pdf

    FDA
    12 Jul 2017
    Share Share
    Aurobindo Pharma's Generic Ropivacaine Hydrochloride Approved in USA
    Aurobindo Pharma's Generic Ropivacaine Hydrochloride Approved in USA

    https://www.pharmacompass.com/pdf/news/aurobindo-pharmas-generic-ropivacaine-hydrochloride-approved-in-usa-1468664522.pdf

    FDA
    13 Jul 2016
    Share Share
    Akorn Inc's Generic Ropivacaine Hydrochloride approved in US as anesthesia
    Akorn Inc's Generic Ropivacaine Hydrochloride approved in US as anesthesia

    https://www.pharmacompass.com/pdf/news/akorn-incs-generic-ropivacaine-hydrochloride-approved-in-us-as-anesthesia-1460633015.pdf

    FDA
    11 Apr 2016
    Share Share
    Cipla inks pact with US firm for Ropivacaine infusion system
    Cipla inks pact with US firm for Ropivacaine infusion system

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-inks-pact-with-us-firm-for-ropivacaine-infusion-system/articleshow/50467682.cms

    ECONOMIC TIMES
    07 Jan 2016
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Chemwerth Ropivacaine HCl

    Access Virtual Booth

    Contact Supplier

    View Presentation

    CHSD-Ropivacaine-Hydrochloride

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search